Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe.[3] It is largest pharma company in India and the fourth largest specialty generic pharmaceutical company in the world,[4] with a total revenue of over US$4.5 billion as of June 2021.[5] The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals.[4] Its API products include Absorica, Acamprosate Calcium, Alendronate Sodium, Amifostine trihydrate, Budensonide and Carvedilol.[6]
| Type | Public |
|---|
| ISIN | INE044A01036 |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1983 |
| Founder | Dilip Shanghvi |
| Headquarters | , |
Area served | Worldwide |
Key people | Dilip Shanghvi (MD) |
| Products | |
| Revenue |  ₹39,576 crore (US$5.0 billion) (2022) |
| ₹4,481 crore (US$560 million) (2022) | |
| ₹3,405 crore (US$430 million) (2022) | |
| Total assets | ₹69,799 crore (US$8.7 billion) (2022) |
| Total equity | ₹48,011 crore (US$6.0 billion) (2022) |
Number of employees | 37,000+ (2021) |
| Website | sunpharma |
| Footnotes / references | |
SPARC[edit]
In 2007, Sun Pharma demerged its innovative R&D arm, and listed it separately on the stock market as the Sun Pharma Advanced Research Company Ltd. (NSE: SPARC, BSE: 532872). In 2013, SPARC declared revenue of ₹873 million.[31] SPARC focuses on new chemical entities (NCE) research and new drug delivery systems and offers an annual update[32] of its pipeline (NDDS).[33]
Awards[edit]
Sun Pharma stood second in the India's Most Reputed Brands (Pharmaceutical) list [34] in a study conducted by BlueBytes,[35] a leading Media Analytics firm in association with TRA Research,[36] a brand insights organization (both a part of the Comniscient Group).
2019[edit]
- CSR subsidiary Foundation for Disease Elimination and Control of India conferred with Mahatma Award for Social Good 2019[37]
- Mobile Healthcare Unit project recognised as the Best Public Health Initiative by ACEF Asian Leadership Forum[38]
2020[edit]
- Listed among the Forbes World's Best Employers 2020[39]
- Volini named in Nielsen BASES Top Breakthrough Innovation Winners India 2020 list[40]
2021[edit]
- Received the Golden Peacock Award for Corporate Social Responsibility, 2020[41]
- Won the Dun & Bradstreet India Corporate Award under the Sectoral Performance-based category- Pharmaceuticals[42]
- Bagged the Distribution Industry Award for Notable Achievements in Healthcare (DIANA) award for ‘Best New Product Introduction/Promotion’ at the Annual Healthcare Distribution Alliance Conference 2021[43]
- Recognized as the Best Innovative Company of the Year 2021 at Indo-American Corporate Excellence Awards[44]
No comments:
Post a Comment